Sandra M. Gawchik

1.2k total citations
28 papers, 894 citations indexed

About

Sandra M. Gawchik is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra M. Gawchik has authored 28 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 18 papers in Immunology and Allergy and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra M. Gawchik's work include Asthma and respiratory diseases (19 papers), Allergic Rhinitis and Sensitization (18 papers) and Respiratory and Cough-Related Research (11 papers). Sandra M. Gawchik is often cited by papers focused on Asthma and respiratory diseases (19 papers), Allergic Rhinitis and Sensitization (18 papers) and Respiratory and Cough-Related Research (11 papers). Sandra M. Gawchik collaborates with scholars based in United States, Denmark and Bulgaria. Sandra M. Gawchik's co-authors include Jennifer Maloney, Hendrik Nolte, David P. Skoner, Michael S. Blaiss, Ruji Yao, Bruce M. Prenner, David S. Reasner, Michael Noonan, Stanley Goldstein and Amarjot Kaur and has published in prestigious journals such as PEDIATRICS, Journal of Allergy and Clinical Immunology and Otolaryngology.

In The Last Decade

Sandra M. Gawchik

26 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra M. Gawchik United States 16 723 589 291 238 107 28 894
Harold B. Kaiser United States 21 993 1.4× 936 1.6× 486 1.7× 127 0.5× 32 0.3× 45 1.2k
Rubaiyat Haque United Kingdom 9 231 0.3× 85 0.1× 233 0.8× 97 0.4× 101 0.9× 22 428
Hanne H. Villesen Denmark 9 365 0.5× 297 0.5× 112 0.4× 143 0.6× 18 0.2× 14 470
G Riario-Sforza Italy 10 168 0.2× 167 0.3× 89 0.3× 68 0.3× 63 0.6× 40 327
Stanislaus Ting United States 12 144 0.2× 111 0.2× 78 0.3× 60 0.3× 31 0.3× 21 313
Jeffrey A. Yung United States 4 284 0.4× 73 0.1× 85 0.3× 26 0.1× 19 0.2× 6 489
W. Skassa-Brociek France 8 319 0.4× 418 0.7× 75 0.3× 224 0.9× 21 0.2× 10 495
Stephen O'Hickey United Kingdom 11 295 0.4× 86 0.1× 233 0.8× 13 0.1× 108 1.0× 11 465
A. Tuncer Türkiye 12 332 0.5× 209 0.4× 193 0.7× 46 0.2× 32 0.3× 22 464
Kobi Sade Israel 11 144 0.2× 150 0.3× 76 0.3× 80 0.3× 128 1.2× 18 359

Countries citing papers authored by Sandra M. Gawchik

Since Specialization
Citations

This map shows the geographic impact of Sandra M. Gawchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra M. Gawchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra M. Gawchik more than expected).

Fields of papers citing papers by Sandra M. Gawchik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra M. Gawchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra M. Gawchik. The network helps show where Sandra M. Gawchik may publish in the future.

Co-authorship network of co-authors of Sandra M. Gawchik

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra M. Gawchik. A scholar is included among the top collaborators of Sandra M. Gawchik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra M. Gawchik. Sandra M. Gawchik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skoner, David P., et al.. (2015). Intranasal Triamcinolone and Growth Velocity. PEDIATRICS. 135(2). e348–e356. 18 indexed citations
2.
Maloney, Jennifer, Bruce M. Prenner, David I. Bernstein, et al.. (2015). Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites. Annals of Allergy Asthma & Immunology. 116(1). 59–65. 39 indexed citations
3.
Nolte, Hendrik, Jacques Hébert, Gary Berman, et al.. (2013). Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Annals of Allergy Asthma & Immunology. 110(6). 450–456.e4. 84 indexed citations
5.
Gawchik, Sandra M.. (2011). Latex Allergy. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 78(5). 759–772. 20 indexed citations
6.
Blaiss, Michael S., Jennifer Maloney, Hendrik Nolte, et al.. (2011). Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. Journal of Allergy and Clinical Immunology. 127(1). 64–71.e4. 194 indexed citations
7.
Maloney, Jennifer, David P. Skoner, Hendrik Nolte, Sandra M. Gawchik, & Michael S. Blaiss. (2011). Efficacy of Timothy Grass Allergy Immunotherapy Tablet During Peak Grass Pollen Season in North American Children and Adolescents. Journal of Allergy and Clinical Immunology. 127(2). AB48–AB48. 15 indexed citations
8.
Bensch, George, Leon S. Greos, Sandra M. Gawchik, Euloge Kpamegan, & Ken B. Newman. (2011). Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: A randomized, double-blind, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 107(4). 323–329. 16 indexed citations
10.
Kaliner, Michael, et al.. (2009). Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 25‐29, 2009. Allergy and Asthma Proceedings. 30(2). 210–210. 1 indexed citations
11.
Hampel, Frank C., Ashish Kumar Nayak, Nathan Segall, et al.. (2009). Research abstracts presented at the Southwest Allergy Forum, January 14‐18, 2009. Allergy and Asthma Proceedings. 30(2). 209–209. 1 indexed citations
12.
Gawchik, Sandra M., et al.. (2009). Pollinex Quattro Tree: allergy vaccine. Expert Opinion on Biological Therapy. 9(3). 377–382. 21 indexed citations
13.
Macy, Eric, Jonathan A. Bernstein, Mariana Castells, et al.. (2007). Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Annals of Allergy Asthma & Immunology. 98(2). 172–174. 110 indexed citations
14.
Gawchik, Sandra M., et al.. (2003). Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Annals of Allergy Asthma & Immunology. 90(4). 416–421. 77 indexed citations
15.
Gawchik, Sandra M., et al.. (2000). A Risk-Benefit Assessment of Intranasal Triamcinolone Acetonide in Allergic Rhinitis. Drug Safety. 23(4). 309–322. 24 indexed citations
16.
Rooklin, Anthony R., Marion C. Kagel, & Sandra M. Gawchik. (2000). Dysphagia—A Cough Masquerader. Pediatric Asthma Allergy & Immunology. 14(3). 231–234. 1 indexed citations
17.
Gawchik, Sandra M., et al.. (1999). The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. Journal of Allergy and Clinical Immunology. 103(4). 615–621. 95 indexed citations
18.
Gawchik, Sandra M., et al.. (1995). The Use of Nasal Corticosteroids in Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 9(1). 25–38. 6 indexed citations
19.
Bronsky, Edwin A., Steven R. Findlay, Sandra M. Gawchik, et al.. (1995). Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 96(2). 139–147. 50 indexed citations
20.
Gawchik, Sandra M. & Herbert C. Mansmann. (1978). Long-Term Hospitalization in the Management of Intractable Bronchial Asthma. Pediatric Annals. 7(1). 112–119. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026